Te-Sheng Chang

473 total citations
7 papers, 353 citations indexed

About

Te-Sheng Chang is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Te-Sheng Chang has authored 7 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hepatology, 4 papers in Epidemiology and 2 papers in Oncology. Recurrent topics in Te-Sheng Chang's work include Liver Disease Diagnosis and Treatment (4 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Liver Disease and Transplantation (2 papers). Te-Sheng Chang is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Liver Disease and Transplantation (2 papers). Te-Sheng Chang collaborates with scholars based in Taiwan. Te-Sheng Chang's co-authors include Yen‐Hua Huang, Yu-Chih Wu, Kam-Fai Lee, Ching‐Chi Chi, Yung‐Che Kuo, Shui‐Yi Tung, Ying-Huang Tsai, Yu-Ting Su, Muh‐Hwa Yang and Jun‐Jen Liu and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and The American Journal of Gastroenterology.

In The Last Decade

Te-Sheng Chang

7 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Te-Sheng Chang Taiwan	6	146	120	107	95	82	7	353
Yeben Qian China	12	158 1.1×	65 0.5×	95 0.9×	50 0.5×	56 0.7×	24	334
Anal Desai United States	5	268 1.8×	37 0.3×	74 0.7×	58 0.6×	53 0.6×	5	412
Liye Tao China	9	170 1.2×	93 0.8×	124 1.2×	68 0.7×	59 0.7×	26	353
Lun Qin China	6	267 1.8×	127 1.1×	242 2.3×	76 0.8×	117 1.4×	7	532
Lianying Ge China	12	163 1.1×	86 0.7×	112 1.0×	101 1.1×	65 0.8×	22	354
Shujie Pang China	8	89 0.6×	22 0.2×	60 0.6×	26 0.3×	52 0.6×	22	282
Yoriko Takahashi Japan	12	283 1.9×	13 0.1×	107 1.0×	77 0.8×	62 0.8×	16	368
Hiroaki Furuyama Japan	8	100 0.7×	103 0.9×	67 0.6×	52 0.5×	107 1.3×	23	295
Motoyuki Yamagata Japan	9	101 0.7×	147 1.2×	54 0.5×	71 0.7×	79 1.0×	24	351
Zhi‐Hong Xian China	10	138 0.9×	113 0.9×	98 0.9×	75 0.8×	70 0.9×	24	357

Countries citing papers authored by Te-Sheng Chang

Since Specialization

Citations

This map shows the geographic impact of Te-Sheng Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Te-Sheng Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Te-Sheng Chang more than expected).

Fields of papers citing papers by Te-Sheng Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Te-Sheng Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Te-Sheng Chang. The network helps show where Te-Sheng Chang may publish in the future.

Co-authorship network of co-authors of Te-Sheng Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Te-Sheng Chang. A scholar is included among the top collaborators of Te-Sheng Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Te-Sheng Chang. Te-Sheng Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Pan, Kuo‐Li, et al.. (2025). Prevalence-based screening by anti-HCV reflex HCV antigen test and accessible post-screening care towards elimination of hepatitis C in rural villages. BMC Gastroenterology. 25(1). 400–400. 1 indexed citations

2.

Chang, Te-Sheng, Ying-Huang Tsai, Chun‐Hsien Chen, et al.. (2020). Limited effects of antibiotic prophylaxis in patients with Child–Pugh class A/B cirrhosis and upper gastrointestinal bleeding. PLoS ONE. 15(2). e0229101–e0229101. 8 indexed citations

3.

Su, Yu-Ting, Ching‐Chi Chi, Yung‐Che Kuo, et al.. (2019). DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation. Journal of Experimental & Clinical Cancer Research. 38(1). 10–10. 98 indexed citations

4.

Chang, Te-Sheng, Chi‐Long Chen, Yu-Chih Wu, et al.. (2016). Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma. PLoS ONE. 11(2). e0149897–e0149897. 39 indexed citations

5.

Chang, Te-Sheng, Yu-Chih Wu, Ching‐Chi Chi, et al.. (2015). Activation of IL6/IGFIR Confers Poor Prognosis of HBV-Related Hepatocellular Carcinoma through Induction of OCT4/NANOG Expression. Clinical Cancer Research. 21(1). 201–210. 80 indexed citations

6.

Wu, Yu-Chih, et al.. (2015). TGF-βI Regulates Cell Migration through Pluripotent Transcription Factor OCT4 in Endometriosis. PLoS ONE. 10(12). e0145256–e0145256. 31 indexed citations

7.

Chang, Te-Sheng, Yu-Chih Wu, Shui‐Yi Tung, et al.. (2015). Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis. The American Journal of Gastroenterology. 110(6). 836–844. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact